Microbe-drug association (MDA) prediction is of great importance for understanding drug action mechanisms and exploring microbiome-based therapeutic strategies. However, when confronted with extremely sparse biological networks with pronounced structural heterogeneity, existing methods often struggle to simultaneously model global topological dependencies and local structural disparities. To address these challenges, we propose MuSeL, a multi-scale adaptive graph representation learning framework that jointly mitigates the above issues from two complementary perspectives: global topology modeling and local structure optimization. Specifically, we develop a spectral kernel attention mechanism that leverages the normalized Laplacian and chebyshev polynomial expansion to efficiently capture multi-scale global topological relations in the spectral domain. Meanwhile, we construct a structure-aware self-adaptive sampling module that dynamically adjusts neighborhood sampling based on node clustering coefficients and degree centrality, thereby improving the reliability of local structural and feature representations. Finally, the fused multi-scale node embeddings are fed into a prediction module to estimate MDA scores. Extensive experiments show that outperforms existing mainstream models, while ablation studies and case analyses further validate its effectiveness and robustness. Overall, MuSeL provides a practical computational framework for prioritizing candidate MDAs, supporting downstream biological validation and drug repurposing research.
Yuehu Wu, Lei Wang, Zhengwei Li et al.· Proceedings of the 32nd ACM...· 0 citations
A novel committor learning framework grounded in the AlphaFold 3 paradigm is proposed that elucidates how ligand substituents regulate the ratio between distinct binding pathways, offering new perspectives for structure-based drug design.
Jintu Zhang, Zichang Jin, Huifeng Zhao et al.· 0 citations